Fangfang Jin

机构：Zhejiang Chinese Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College · ORCID：0000-0002-8983-2529

发表论文 27 篇 · 总被引 238 次 · h-index 9

代表论文

• Discovery of potent and orally bioavailable inhibitors of Human Uric Acid Transporter 1 (hURAT1) and binding mode prediction using homology model (2015 · Bioorganic & Medicinal Chemistry Letters · 被引 35)
• Dual-aptamer-engineered M1 macrophage with enhanced specific targeting and checkpoint blocking for solid-tumor immunotherapy (2022 · Molecular Therapy · 被引 32)
• Discovery of Imidazoisoindole Derivatives as Highly Potent and Orally Active Indoleamine-2,3-dioxygenase Inhibitors (2019 · ACS Medicinal Chemistry Letters · 被引 26)
• Super Dominant Pathobiontic Bacteria in the Nasopharyngeal Microbiota Cause Secondary Bacterial Infection in COVID-19 Patients (2022 · Microbiology Spectrum · 被引 24)
• Coexistence of low levels of HBsAg and high levels of anti-HBs may increase risk of hepatocellular carcinoma in chronic hepatitis B patients with high HBV load (2019 · The Brazilian Journal of Infectious Diseases · 被引 20)
• Chinese herbal medicine for the treatment of chronic fatigue syndrome: A systematic review and meta-analysis (2022 · Frontiers in Pharmacology · 被引 18)